Search for: "Greene et al v. Pfizer, Inc."
Results 1 - 11
of 11
Sorted by Relevance
|
Sort by Date
10 Nov 2021, 4:00 am
BCE Inc. et al (T-113-18), under reserve Rovi Guides, Inc. et al v. [read post]
17 Feb 2010, 5:10 am
Actavis Elizabeth LLC, et al. [read post]
18 Sep 2008, 8:56 pm
Conference of September 29, 2008 __________________ Docket: 07-811 Case name: Morris, et al. v Center for Bio-Ethical Reform, Inc. et al. [read post]
30 Nov 2015, 3:34 am
Never Too Late 70 [week ending on Sunday 1 November] – Case T-309/13 Enosi Mastichoparagogon Chiou v OHIM, Gaba International Holding GmbH | Sixteen millions IPKats | Tomaydo-Tomahhdo LLC v George Vozray et al | Lookalike packaging | Parasite copying | 3D printing | Labouring the point? [read post]
18 Mar 2011, 10:04 am
Pfizer, 196 F. [read post]
11 Jan 2008, 9:00 am
: (IP Spotlight)PharmaIndia: Trade mark assignment under scrutiny in a case of deceptive similarity - Doctor Morepen Limited v Yash Pharma Laboratories Limited: (Mondaq),Arrow v Merck - An early route to market for generics? [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
25 Apr 2015, 11:03 am
See also Manual at 614 n. 198., citing Ofer Shpilberg, et al., The Next Stage: Molecular Epidemiology, 50 J. [read post]
2 May 2008, 7:00 am
: (Patent Baristas), US: How to avoid a permanent injunction: the lessons of Amgen v Hoffman-LaRoche: (Patent Docs), US: Jarvik Heart’s PTE request based on PMA shell/module submission dates flatlines; ruling on initiation of PTE ‘review period’ mirrors FDA policy for ‘fast track’ products: (FDA Law Blog) Pharma & Biotech - Products Kytril (Granisetron) – Exclusivity ‘parking’ still… [read post]
11 Jul 2008, 4:30 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: ACTA continues to be discussed and debated: (Michael Geist), (Intellectual Property Watch), (Public Knowledge), (Techdirt), (Managing Intellectual Property), (Public Knowledge), (Public Knowledge), (Public Knowledge), Apotex challenge to Acular LS patent barred by res judicata: Roche Palo Alto & Allergan v Apotex:… [read post]
13 Jul 2021, 10:58 am
In the United States (US), as for most developed countries,[6] trade policy and IP standards have consistently been linked, a pattern which can (at least partially) be traced back to extensive lobbying by senior management at US-based technology and pharmaceutical firms.[7] For example, since at least the 1980s, Pfizer Inc. has been involved in mobilizing other US firms and stakeholders to lobby US policymakers on the issue of international IP protection. [read post]
